Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia
Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), E. Polli(University of Milan), C. Annaloro(University of Milan), Fabrizio Ganzina(Ospedale San Carlo), Anna Teresa Maiolo(Policlinico San Matteo Fondazione), Enrico Pogliani(Azienda Ospedaliera San Gerardo), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 19
Related Papers
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
Angiogenesis in myelodysplastic syndromes
|British Journal of Cancer|1999|272